Partnering with Patient Organizations

At Hansa, we recognize the vital role patient advocacy groups (PAGs) play in advancing healthcare and supporting people with rare immunologic conditions. By partnering with non-profit PAGs and other non-profit organizations engaged directly or indirectly in healthcare and the support of patients Hansa aims to foster a more patient-centric approach to drug development, access and education. We are committed to fostering meaningful partnerships that empower patients and catalyze positive change. Together, we can make a difference in the lives of patients.

Our partnerships with patient advocacy organizations is guided by three fundamental principles:

1. Independence: We respect the autonomy of patient advocacy groups and collaborate with them as equal partners.
2. Respect and clarity of purpose: We value the perspectives and contributions of patient advocates. We actively listen, engage in open dialogue, and treat each other with respect.
3. Transparency: Transparency is essential. We disclose any financial support provided to patient advocacy organizations.

The table below outlines the funding we provided to patient advocacy groups in 2023.